6533b837fe1ef96bd12a1eb2
RESEARCH PRODUCT
PIN31: THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC)
Jesse GreenAntonio CraxìSean D. SullivanK. K. PatelC. De CarliGiovanni GiulianiAlfredo Albertisubject
medicine.medical_specialtyCost effectivenessbusiness.industryHealth PolicyRibavirinPublic Health Environmental and Occupational HealthGastroenterologychemistry.chemical_compoundchemistryChronic hepatitisInternal medicinemedicinebusinessInterferon alfamedicine.drugPeginterferon alfa-2ayear | journal | country | edition | language |
---|---|---|---|---|
2003-05-01 | Value in Health |